Pakistan Business News API

{
    "totalArticles": 334264,
    "articles": [
        {
            "id": "f7e73579cf6bea59a7b6f4ee0ef0cc4d",
            "title": "What is ‘China Shock 2.0’ and should the west be worried?",
            "description": "In 2025, profits in China's high-tech manufacturing sector rose 13.3% year on year, outpacing the broader industrial sector by nearly 13 percentage points.\nThat number sits at the centre of a debate...",
            "content": "In 2025, profits in China's high-tech manufacturing sector rose 13.3% year on year, outpacing the broader industrial sector by nearly 13 percentage points.\nThat number sits at the centre of a debate now rippling through trade ministries, economics de... [2402 chars]",
            "url": "https://www.thenews.com.pk/latest/1400422-what-is-china-shock-20-and-should-the-west-be-worried",
            "image": "https://www.thenews.com.pk/assets/uploads/2026-04-26/1400422_044540_updates.jpg",
            "publishedAt": "2026-04-26T11:39:22Z",
            "lang": "en",
            "source": {
                "id": "d6d8d1da5b3ea3eb10f02262522a0d6d",
                "name": "The News International",
                "url": "https://www.thenews.com.pk"
            }
        },
        {
            "id": "101635f2cffb71481d4df8eb1fb7c743",
            "title": "The great energy pivot: US oil and Chinese solar are the winners in Trump’s war on Iran",
            "description": "Exposure of world’s reliance on Middle East supplies accelerates global shift towards new energy superpowers",
            "content": "In the open seas, an armada of empty tankers has quietly turned west. A record number of super-sized vessels are now heading to the US, where oil drillers and refineries are preparing to profit from Donald Trump’s war in the Middle East.\nAlmost 30 of... [8968 chars]",
            "url": "https://www.theguardian.com/business/2026/apr/26/more-than-oil-prices-iran-war-threatens-to-reshape-global-energy-order",
            "image": "https://i.guim.co.uk/img/media/27d8a9ac11e4a75092f87b8da906b5b86577af0e/447_0_4466_3573/master/4466.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&precrop=40:21,offset-x50,offset-y0&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=499ee43c72d0050a9fd39194d11b62ea",
            "publishedAt": "2026-04-26T11:01:00Z",
            "lang": "en",
            "source": {
                "id": "558a003a7a0164e924408edec7e99f99",
                "name": "The Guardian",
                "url": "https://www.theguardian.com"
            }
        },
        {
            "id": "3f0566df7dd5cfb235507e2050720c80",
            "title": "Treatment HBsAg Rebound at APASL 2026",
            "description": "- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes,...",
            "content": "- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 IU/mL and HBV DNA rebound infrequent and not associated with cl... [4414 chars]",
            "url": "https://www.prnewswire.com/news-releases/brii-bio-presents-cross-study-analysis-of-post-treatment-hbsag-rebound-at-apasl-2026-302752606.html",
            "image": "https://www.prnewswire.com/content/dam/prnewswire/icons/2019-Q4-PRN-Icon-32-32.png",
            "publishedAt": "2026-04-26T11:00:00Z",
            "lang": "en",
            "source": {
                "id": "4e4307a07d2ce1e31acaf932954d3dd9",
                "name": "PR Newswire",
                "url": "https://www.prnewswire.com"
            }
        }
    ]
}